Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma
- PMID: 20171681
- DOI: 10.1016/j.juro.2009.12.035
Histological subtype is an independent predictor of outcome for patients with renal cell carcinoma
Abstract
Purpose: There are significant differences in clinicopathological features among renal cell carcinoma histological subtypes but controversy exists regarding the independent impact of histological subtype on patient outcome after nephrectomy. We examined the significance of histological subtype on progression to distant metastasis and cancer specific death after nephrectomy.
Materials and methods: In a retrospective review of our institutional nephrectomy registry we identified 3,062 patients treated surgically for clear cell, papillary or chromophobe renal cell carcinoma between 1970 and 2003.
Results: We identified 2,466 patients (80.5%) with clear cell, 438 (14.3%) with papillary and 158 (5.2%) with chromophobe renal cell carcinoma. There were significant differences in age at surgery, gender, symptoms at presentation, tumor size, stage and grade, tumor necrosis, sarcomatoid differentiation and multifocality among the 3 renal cell carcinoma subtypes (p <0.01 for all). A significant difference in metastasis-free and cancer specific survival existed between patients with clear cell renal cell carcinoma and the 2 other subtypes, although no significant difference in these outcomes was identified between patients with the papillary and chromophobe subtypes. The clear cell renal cell carcinoma subtype remained a significant predictor of metastasis (HR 2.76, 95% CI 2.05-3.73) and cancer specific death (HR 1.77, 95% CI 1.38-2.26, each p <0.001) after multivariate adjustment for the features listed above.
Conclusions: Histological subtype is an independent predictor of progression to distant metastasis and cancer specific death in patients with renal cell carcinoma.
Copyright (c) 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.
Comment in
-
Editorial comment.J Urol. 2010 Apr;183(4):1315-6; discussion 1316. doi: 10.1016/j.juro.2009.12.125. Epub 2010 Feb 19. J Urol. 2010. PMID: 20171660 No abstract available.
-
Re: histological subtype is an independent predictor of outcome for patients with renal cell carcinoma: B. C. Leibovich, C. M. Lohse, P. L. Crispen, S. A. Boorjian, R. H. Thompson, M. L. Blute and J. C. Cheville J Urol 2010; 183: 1309–1316.J Urol. 2010 Nov;184(5):2211; author reply 2211-2. doi: 10.1016/j.juro.2010.06.125. J Urol. 2010. PMID: 20884030 No abstract available.
Similar articles
-
The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.J Urol. 2003 Apr;169(4):1276-81. doi: 10.1097/01.ju.0000051883.41237.43. J Urol. 2003. PMID: 12629342
-
Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.BJU Int. 2012 Jul;110(1):76-83. doi: 10.1111/j.1464-410X.2011.10690.x. Epub 2011 Nov 1. BJU Int. 2012. PMID: 22044519
-
Long-term survival of patients with unilateral sporadic multifocal renal cell carcinoma according to histologic subtype compared with patients with solitary tumors after radical nephrectomy.Urology. 2004 Sep;64(3):462-7. doi: 10.1016/j.urology.2004.04.016. Urology. 2004. PMID: 15351571 Review.
-
Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma.J Urol. 2006 Oct;176(4 Pt 1):1332-7; discussion 1337-8. doi: 10.1016/j.juro.2006.06.021. J Urol. 2006. PMID: 16952624
-
[Papillary renal cell carcinoma: morphological subtypes, clinical and histopathological considerations].Prog Urol. 2010 Jun;20(6):393-401. doi: 10.1016/j.purol.2010.02.003. Epub 2010 Mar 25. Prog Urol. 2010. PMID: 20538202 Review. French.
Cited by
-
The utilization of single-cell sequencing technology in investigating the immune microenvironment of ccRCC.Front Immunol. 2023 Nov 27;14:1276658. doi: 10.3389/fimmu.2023.1276658. eCollection 2023. Front Immunol. 2023. PMID: 38090562 Free PMC article. Review.
-
Validation of prognostic signature and exploring the immune-related mechanisms for NR3C2 in clear cell renal cell carcinoma.Transl Cancer Res. 2023 Oct 31;12(10):2518-2532. doi: 10.21037/tcr-23-846. Epub 2023 Oct 24. Transl Cancer Res. 2023. PMID: 37969386 Free PMC article.
-
NCCN Guidelines Insights: Kidney Cancer, Version 1.2021.J Natl Compr Canc Netw. 2020 Sep;18(9):1160-1170. doi: 10.6004/jnccn.2020.0043. J Natl Compr Canc Netw. 2020. PMID: 32886895 Free PMC article.
-
Stage IA papillary and chromophobe renal cell carcinoma: effectiveness of cryoablation and partial nephrectomy.Insights Imaging. 2024 Jul 6;15(1):171. doi: 10.1186/s13244-024-01749-x. Insights Imaging. 2024. PMID: 38971873 Free PMC article.
-
Efficacy of First-Line Targeted Therapy in Real-World Korean Patients with Metastatic Renal Cell Carcinoma: Focus on Sunitinib and Pazopanib.J Korean Med Sci. 2018 Nov 22;33(51):e325. doi: 10.3346/jkms.2018.33.e325. eCollection 2018 Dec 17. J Korean Med Sci. 2018. PMID: 30546281 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical